Obesity Won’t Be Solely Defined by BMI under New Plan for Diagnosis by Global Experts

A man uses measuring tape on his waist in California on Jan. 9, 2025. (AP)
A man uses measuring tape on his waist in California on Jan. 9, 2025. (AP)
TT

Obesity Won’t Be Solely Defined by BMI under New Plan for Diagnosis by Global Experts

A man uses measuring tape on his waist in California on Jan. 9, 2025. (AP)
A man uses measuring tape on his waist in California on Jan. 9, 2025. (AP)

A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need treatment for the disease caused by excess body fat.

Under recommendations released Tuesday night, obesity would no longer be defined solely by BMI, a calculation of height and weight, but combined with other measurements, such as waist circumference, plus evidence of health problems tied to extra pounds.

Obesity is estimated to affect more than 1 billion people worldwide. In the US, about 40% of adults have obesity, according to the US Centers for Disease Control and Prevention.

"The whole goal of this is to get a more precise definition so that we are targeting the people who actually need the help most," said Dr. David Cummings, an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal.

The report introduces two new diagnostic categories: clinical obesity and pre-clinical obesity.

People with clinical obesity meet BMI and other markers of obesity and have evidence of organ, tissue or other problems caused by excess weight. That could include heart disease, high blood pressure, liver or kidney disease or chronic severe knee or hip pain. These people would be eligible for treatments, including diet and exercise interventions and obesity medications.

People with pre-clinical obesity are at risk for those conditions, but have no ongoing illness, the report says.

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as a BMI of 30 or more. But people with excess body fat do not always have a BMI above 30, the report notes. And people with high muscle mass — football players or other athletes — may have a high BMI despite normal fat mass.

Under the new criteria, about 20% of people who used to be classified as obese would no longer meet the definition, preliminary analysis suggests. And about 20% of people with serious health effects but lower BMI would now be considered clinically obese, experts said.

"It wouldn't dramatically change the percentage of people being defined as having obesity, but it would better diagnose the people who really have clinically significant excess fat," Cummings said.

The new definitions have been endorsed by more than 75 medical organizations around the world, but it's not clear how widely or quickly they could be adopted in practice. The report acknowledges that implementation of the recommendations "will carry significant costs and workforce implications."

A spokesman for the health insurance trade group AHIP, formerly known as America's Health Insurance Plans, said "it's too early at this point to gauge how plans will incorporate these criteria into coverage or other policies."

There are practical issues to consider, said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. Measuring waist circumference sounds simple, but protocols differ, many doctors aren't trained accurately and standard medical tape measures aren't big enough for many people with obesity.

In addition, determining the difference between clinical and pre-clinical obesity would require a comprehensive health assessment and lab tests, she noted.

"For a new classification system to be widely adopted, it would also need to be extremely quick, inexpensive, and reliable," she said.

The new definitions are likely to be confusing, said Kate Bauer, a nutrition expert at the University of Michigan School of Public Health.

"The public likes and needs simple messages. I don't think this differentiation is going to change anything," she said.

Overhauling the definition of obesity will take time, acknowledged Dr. Robert Kushner, an obesity expert at the Northwestern Feinberg School of Medicine and a co-author of the report.

"This is the first step in the process," he said. "I think it's going to begin the conversation."



US Bans Red Food Dye over Possible Cancer Risk

Fruit by the Foot, a product that uses Red Dye No 3, can be seen on a shelf at a supermarket in this illustration photograph on December 27, 2024 - AFP
Fruit by the Foot, a product that uses Red Dye No 3, can be seen on a shelf at a supermarket in this illustration photograph on December 27, 2024 - AFP
TT

US Bans Red Food Dye over Possible Cancer Risk

Fruit by the Foot, a product that uses Red Dye No 3, can be seen on a shelf at a supermarket in this illustration photograph on December 27, 2024 - AFP
Fruit by the Foot, a product that uses Red Dye No 3, can be seen on a shelf at a supermarket in this illustration photograph on December 27, 2024 - AFP

Outgoing US President Joe Biden's administration on Wednesday announced a ban on Red Dye No 3, a controversial food and drug coloring long known to cause cancer in animals.

Decades after scientific evidence first raised alarm, Red 3, as it is also called, is currently used in nearly 3,000 food products in the United States, according to the nonprofit Environmental Working Group.

"FDA is revoking the authorized uses in food and ingested drugs of FD&C Red No 3 in the color additive regulations," said a document from the Department of Health and Human Services, published in the Federal Register on Wednesday, AFP reported.

The decision follows a petition filed in November 2022 by the Center for Science in the Public Interest (CSPI) and other advocacy groups, which cited the "Delaney Clause" -- a provision mandating the prohibition of any color additive shown to cause cancer in humans or animals.

Notably, the FDA determined as early as 1990 that Red 3 should be banned in cosmetics because of its link to thyroid cancer in lab rats.

However, the additive continued to be used in foods, largely due to resistance from the food industry. Manufacturers of maraschino cherries, for example, relied on Red 3 to maintain the iconic red hue of their products.

It's also present in thousands of candies, snacks and fruit products.

The United States is one of the last major economies to take action on the dye. The European Union prohibited its use in 1994, with similar bans implemented in Japan, China, the UK, Australia and New Zealand.

CSPI hailed the decision as overdue and expressed hope it would lead to further action against other potentially harmful chemicals in food.

"They don't add any nutritional value, they don't preserve the food -- they're just there to make food look pretty," Thomas Galligan, a scientist with CSPI, told AFP.

"There's growing discussion across the political spectrum about food additives and chemicals, which reflects ongoing failures by the FDA."